Carl N. Kraus serves as Executive at Aquestive Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Carl N. Kraus has executed 4 insider transactions totaling $141.9K, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 15, 2025 involved selling 20,272 shares valued at $141.9K.
Carl N. Kraus currently holds 282,475 shares of Aquestive Therapeutics, Inc. (AQST), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Carl N. Kraus has been a net seller of AQST stock. They have purchased $0 and sold $141.9K worth of shares.
Carl N. Kraus's most recent insider trade was on Oct 15, 2025, when they sold 20,272 shares at $7.00 per share.
Get notified when new Form 4 filings are submitted
| $3.43 |
| Discretionary |
| Mar 7, 2024 | AQST | $0 | Award | 112,500 | $N/A | Discretionary |
| Aug 9, 2023 | AQST | $0 | Award | 150,000 | $N/A | Discretionary |